-
-
-
-
-
-
-
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
-
-
-
-
-
-
-
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
-
-
-
-
-
-
-
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
-
-
-
-
-
-
-
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
-
-
-
-
-
-
-
Theralase Annual General Meeting
-
-
-
-
-
-
-
Theralase(R) Closes Non-Brokered Private Placement
-
-
-
-
-
-
-
Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
-
432,336 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

